Show simple item record

dc.contributor.authorMendiola, Raul A.
dc.contributor.authorFlorentino-Pineda, Ivan
dc.date.accessioned2013-02-08T23:39:33Z
dc.date.available2013-02-08T23:39:33Z
dc.date.issued2009-03
dc.identifier.urihttp://hdl.handle.net/10675.2/934
dc.descriptionPoster - Case Reporten_US
dc.description.abstractObstructive sleep apnea (OSA) in children is most commonly associated with tonsillar and adenoid hypertrophy. Use of opioids and residual amounts of inhaled agents can cause severe respiratory depression and thus represent an added risk to patients with OSA in the immediate postoperative period. Dexmedetomidine, a specific alpha 2-adrenergic receptor agonist, is known for its hypnotic, sedative, analgesic and sympatholytic properties. It potentiates analgesia with the advantages of minimal respiratory compromise, rapid onset and clearance. Because dexmedetomidine has been shown to be effective as an analgesic and sedative agent while minimizing respiratory compromise, it offers a safer alternative as an adjuvant for the anesthetic management of obese pediatric patients with OSA undergoing tonsillectomy and adenoidectomy.
dc.language.isoen_USen_US
dc.publisherSociety for Pediatric Anesthesiaen_US
dc.relation.ispartofseriesSPA;2009-P03
dc.subjectAnesthesiaen_US
dc.subjectPediatricen_US
dc.subjectdexmedetomidineen_US
dc.subjectsleep apneaen_US
dc.titleUse of Dexmedetomidine as Adjuvant for the Anesthetic Management of Obese Children with Obstructive Sleep Apnea Undergoing Tonsillectomy and Adenoidectomyen_US
dc.contributor.corporatenameDepartment of Anesthesiology and Perioperative Medicineen_US
refterms.dateFOA2019-04-10T01:40:33Z
html.description.abstractObstructive sleep apnea (OSA) in children is most commonly associated with tonsillar and adenoid hypertrophy. Use of opioids and residual amounts of inhaled agents can cause severe respiratory depression and thus represent an added risk to patients with OSA in the immediate postoperative period. Dexmedetomidine, a specific alpha 2-adrenergic receptor agonist, is known for its hypnotic, sedative, analgesic and sympatholytic properties. It potentiates analgesia with the advantages of minimal respiratory compromise, rapid onset and clearance. Because dexmedetomidine has been shown to be effective as an analgesic and sedative agent while minimizing respiratory compromise, it offers a safer alternative as an adjuvant for the anesthetic management of obese pediatric patients with OSA undergoing tonsillectomy and adenoidectomy.


Files in this item

Thumbnail
Name:
Mendiola_SPA_GSA2009_SC.pdf
Size:
368.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record